The New York Entrepreneur

Dow Jones Newswires: Lifecore Biomedical stock climbs 19% on $150 million refinancing deal

Read Time:10 Second

Shares of Lifecore Biomedical on Monday climbed 19% to $6.40 in after-hours trading after the company said it secured a new $150 million financing agreement with its long-term customer Alcon.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post : Yelp shares rally on report that activist investor is urging sale
Next post Earnings Results: Zoom stock ticks higher as earnings and forecast top expectations